PROGRESS IN PANCREATIC CANCER LEARNING CENTER
Welcome to Progress in Pancreatic Cancer.
This Learning Center is a freely accessible, educational platform for healthcare providers who treat patients with pancreatic cancer. Our goal is to ensure that you – the practicing clinician – have access to the most accurate, up-to-date information for the treatment of patients with pancreatic cancer.
CME COURSES
Faculty: Daniel Ahn, DO, MS
Credits: 0.5 AMA PRA Category 1 Credit(s)™
Faculty: Andrew H. Ko, MD
Credits: 0.75 AMA PRA Category 1 Credit(s)™
Faculty: Eileen M. O’Reilly, MD
Credits: 0.75 AMA PRA Category 1 Credit(s)™
Faculty: Fadi Braiteh, MD
Credits: 0.75 AMA PRA Category 1 Credit(s)™
READ OUR HANDPICKED ARTICLES AND IMPROVE YOUR KNOWLEDGE
Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis.
Cancer. 2017 Dec 1;123(23):4680-4686.Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
N Engl J Med. 2013 Oct 31;369(18):1691-703.
Tanios Bekaii-Saab, MD, FACP
Professor, Mayo Clinic College of Medicine and Science
Program Co-Leader, GI Cancer, Mayo Clinic Cancer Center
Senior Associate Consultant, Mayo Clinic AZ , USA
